gremlin-1 Inhibitors
The chemical class of gremlin-1 inhibitors constitutes a diverse spectrum of compounds, each designed with unique mechanisms to target the intricate TGF-β and BMP pathways. Kavain, an intriguing natural compound found in kava, stands out as an indirect inhibitor of gremlin-1. This compound operates by suppressing TGF-β signaling, providing valuable insights into the complex crosstalk between kava-derived compounds and cellular responses mediated by the TGF-β pathway. In contrast, direct inhibitors like LDN-193189 and RepSox play pivotal roles in selectively targeting BMP and TGF-β receptor signaling, respectively. By disrupting the downstream events associated with these pathways, these compounds effectively impede the upregulation of gremlin-1. The specificity of LDN-193189 and RepSox offers valuable tools for researchers delving into the regulatory mechanisms governing gremlin-1 within the context of BMP and TGF-β pathways. These inhibitors pave the way for a more nuanced understanding of how gremlin-1 fits into the broader landscape of cellular signaling.
Expanding the repertoire of direct inhibitors, SB-431542, LDN-214117, Galunisertib, GW788388, LY2157299, and SD-208 take center stage by specifically targeting the TGF-β pathway. These compounds exert their inhibitory effects by modulating gremlin-1 expression through the inhibition of TGF-β receptor activation. Each member of this chemical class contributes a unique perspective, unraveling the intricacies of TGF-β-mediated regulation of gremlin-1. SB-431542, for instance, may offer distinct mechanistic insights compared to the others, enriching the toolkit available for researchers aiming to decipher the role of gremlin-1 in diverse physiological and pathological contexts. In conclusion, the chemical class of gremlin-1 inhibitors presents a rich assortment of compounds, each with its distinct characteristics and mechanisms of action.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Kavain (±) | 500-64-1 | sc-201077 sc-201077A | 50 mg 250 mg | $72.00 $300.00 | 2 | |
Kavain, a natural compound from kava, inhibits gremlin-1 indirectly by suppressing TGF-β signaling. By attenuating TGF-β1-induced Smad2/3 phosphorylation, Kavain modulates the TGF-β pathway, impacting gremlin-1 expression. This indirect inhibition provides insights into the crosstalk between Kavain and TGF-β signaling, offering a tool for investigating gremlin-1 regulation in the context of TGF-β-mediated cellular responses. | ||||||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
LDN-193189, a selective BMP type I receptor inhibitor, directly targets the BMP pathway, inhibiting gremlin-1 expression. By blocking BMP receptor signaling, LDN-193189 disrupts the downstream events leading to gremlin-1 upregulation. This direct inhibition provides a specific tool for studying the role of LDN-193189 in modulating gremlin-1 and its implications in BMP pathway regulation. | ||||||
ALK5 Inhibitor II | 446859-33-2 | sc-221234 sc-221234A sc-221234B sc-221234C sc-221234D sc-221234E sc-221234F | 1 mg 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $77.00 $153.00 $219.00 $663.00 $1248.00 $4382.00 $7850.00 | 8 | |
RepSox, a selective TGF-β receptor I kinase inhibitor, directly targets the TGF-β signaling pathway, modulating gremlin-1 expression. By inhibiting TGF-β receptor activation, RepSox interferes with the downstream events leading to gremlin-1 upregulation. This direct inhibition offers a specific tool for investigating the regulatory mechanisms governing gremlin-1 in the context of TGF-β-mediated cellular responses. | ||||||
LDN-214117 | 1627503-67-6 | sc-507451 | 5 mg | $165.00 | ||
LDN-214117, a selective BMP type I receptor inhibitor, directly targets the BMP pathway, inhibiting gremlin-1 expression. By blocking BMP receptor signaling, LDN-214117 disrupts the downstream events leading to gremlin-1 upregulation. This direct inhibition provides a specific tool for studying the role of LDN-214117 in modulating gremlin-1 and its implications in BMP pathway regulation. | ||||||
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $213.00 $359.00 | 3 | |
LY2157299, a selective TGF-β receptor I kinase inhibitor, directly targets the TGF-β signaling pathway, modulating gremlin-1 expression. By inhibiting TGF-β receptor activation, LY2157299 interferes with the downstream events leading to gremlin-1 upregulation. This direct inhibition offers a specific tool for investigating the regulatory mechanisms governing gremlin-1 in the context of TGF-β-mediated cellular responses. | ||||||
GW788388 | 452342-67-5 | sc-363544 sc-363544A | 5 mg 25 mg | $95.00 $384.00 | ||
GW788388, a selective TGF-β receptor I kinase inhibitor, directly targets the TGF-β signaling pathway, influencing gremlin-1 expression. By inhibiting TGF-β receptor activation, GW788388 modulates the downstream events leading to gremlin-1 upregulation. This direct inhibition provides a specific tool for studying the regulatory mechanisms governing gremlin-1 in the context of TGF-β-mediated cellular responses. | ||||||
TGF-β RI Kinase Inhibitor V | 627536-09-8 | sc-203294 | 2 mg | $88.00 | 3 | |
SD-208, a selective TGF-β receptor I kinase inhibitor, directly targets the TGF-β signaling pathway, influencing gremlin-1 expression. By inhibiting TGF-β receptor activation, SD-208 modulates the downstream events leading to gremlin-1 upregulation. This direct inhibition provides a specific tool for studying the regulatory mechanisms governing gremlin-1 in the context of TGF-β-mediated cellular responses. | ||||||